Aliskiren Reduces Morning Blood Pressure in Hypertensive Patients with Diabetic Nephropathy on Hemodialysis

Author： Takenaka Tsuneo   Okayama Mika   Kojima Eriko   Nodaira Yuka   Arai Jonde   Uchida Kosuke   Kikuta Tomohiro   Sueyoshi Keita   Hoshi Hitoshi   Watanabe Yusuke   Takane Hiroshi   Suzuki Hiromichi  

Publisher： Informa Healthcare

ISSN： 1064-1963

Source： Clinical and Experimental Hypertension, Vol.35, Iss.4, 2013-07, pp. : 244-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Our previous study indicated that the exchange from an angiotensin receptor blocker (ARB) to aliskiren reduced morning blood pressure and albuminuria in hypertensive patients with diabetic nephropathy. We extended the above study and assessed the effects of exchanging from an ARB to aliskiren on home blood pressure in hypertensive patients with diabetic nephropathy on chronic hemodialysis. The patients who were persistently hypertensive despite antihypertensive therapy, including ARB, were considered as candidates for the exchange from the ARB to aliskiren. Patients' age and durations of diabetes and hemodialysis were averaged as 62 ± 9 years old, 15 ± 8 and 7 ± 3 years, respectively. Aliskiren decreased morning systolic blood pressure (149 ± 14 to 144 ± 13 mm Hg, n = 30, P < .01) and plasma renin activity (3.5 ± 1.1 to 1.2 ± 0.6 ng/mL/h, P < .01) without changes in serum potassium. Aliskiren also reduced interdialytic weight gain (2.7 ± 0.6 to 2.5 ± 0.5 kg/interval, P < .05) and attenuated the magnitude of intradialytic declines in systolic (−20 ± 11 to −17 ± 10 mm Hg, P < .05) and diastolic blood pressure (−9 ± 6 to −5 ± 5 mm Hg, P < .01). The exchange from an ARB to aliskiren is safe and useful to control home blood pressure in hypertensive hemodialysis patients with diabetic nephropathy. Aliskiren reduced both intradialytic blood pressure drops and interdialytic weight gain in patients with DN.

Related content

Aliskiren Reduces Morning Blood Pressure in Hypertensive Patients with Diabetic Nephropathy

By Takenaka Tsuneo   Nobe Kanako   Okayama Mika   Kojima Eriko   Nodaira Yuka   Sueyoshi Keita   Hoshi Hitoshi   Watanabe Yusuke   Takane Hiroshi   Suzuki Hiromichi  

Clinical and Experimental Hypertension, Vol. 34, Iss. 4, 2012-07 ,pp. : 243-248 (6)

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of Low-Dose Hydrochlorothiazide in Combination with Telmisartan on Early Morning Blood Pressure in Uncontrolled Hypertensive Patients

By Makita Shinji   Abiko Akihiko   Naganuma Yujirou   Tamada Makiko   Nakamura Motoyuki  

Clinical and Experimental Hypertension, Vol. 31, Iss. 2, 2009-04 ,pp. : 105-115 (11)

Informa Healthcare

Access to resources Recommend Favorite

Effect of the 2004 Mid-Niigata Prefecture Earthquake on Home Blood Pressure Measurement in the Morning in Type 2 Diabetic Patients

By Kamoi Kyuzi   Tanaka Midori   Ikarashi Tomoo   Miyakoshi Masashi  

Clinical and Experimental Hypertension, Vol. 28, Iss. 8, 2006-12 ,pp. : 719-729 (11)

Informa Healthcare

Access to resources Recommend Favorite

Blood Pressure and Medication During Long-Term Antihypertensive Therapy Based on Morning Home SBP in Hypertensive Patients: Hypertension Control Based On Home Systolic Pressure (HOSP) Substudy

By Kawano Yuhei   Horio Takeshi   Kamide Kei   Iwashima Yoshio   Yoshihara Fumiki   Nakamura Satoko  

Clinical and Experimental Hypertension, Vol. 32, Iss. 4, 2010-07 ,pp. : 239-243 (5)

Informa Healthcare

Access to resources Recommend Favorite

Perioperative Blood Pressure Variability in the Treated Hypertensive Patients

By Kiyohara Kanako  

Clinical and Experimental Hypertension, Vol. 35, Iss. 4, 2013-07 ,pp. : 291-294 (4)

Informa Healthcare

Access to resources Recommend Favorite